Synergy CHC Corp. Royalty Expense
Synergy CHC Corp. (SNYR) reported Royalty Expense of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2026-05-14
- Synergy CHC Corp. royalty expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Synergy CHC Corp. royalty expense for the quarter ending 2025-12-31 was $1.38K, a 68.54% decline year-over-year.
- Synergy CHC Corp. royalty expense for the quarter ending 2025-09-30 was $2.70K, a 53.15% decline year-over-year.
- Synergy CHC Corp. royalty expense for the quarter ending 2025-06-30 was $3.24K, a 82.77% decline year-over-year.
- Synergy CHC Corp. royalty expense for fiscal 2025 was $11.87K, a 76.92% decline from fiscal 2024.
- Synergy CHC Corp. royalty expense for fiscal 2024 was $51.43K, a 37.90% decline from fiscal 2023.
- Synergy CHC Corp. royalty expense for fiscal 2023 was $82.81K.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 9 month as first filed | Royalty Expense 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $1.38K derived: sum of 2 quarters · filed 2026-05-14 | $4.08K derived: sum of 3 quarters · filed 2026-05-14 | $7.32K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-12-31 | $1.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $4.08K derived: sum of 2 quarters · filed 2026-04-01 | $7.32K derived: sum of 3 quarters · filed 2026-04-01 | $11.87K 10-K · filed 2026-04-01 | |
| 2025-09-30 | $2.70K 10-Q · filed 2025-11-13 | $5.94K derived: sum of 2 quarters · filed 2025-11-13 | $10.49K 10-Q · filed 2025-11-13 | $14.88K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-06-30 | $3.24K 10-Q · filed 2025-08-14 | $7.79K 10-Q · filed 2025-08-14 | $12.18K derived: sum of 3 quarters · filed 2026-05-14 | $17.94K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-03-31 | $4.55K 10-Q · filed 2026-05-14 | $8.94K derived: sum of 2 quarters · filed 2026-05-14 | $14.70K derived: sum of 3 quarters · filed 2026-05-14 | $33.50K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $4.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $10.15K derived: sum of 2 quarters · filed 2026-04-01 | $28.95K derived: sum of 3 quarters · filed 2026-04-01 | $51.43K 10-K · filed 2026-04-01 | |
| 2024-09-30 | $5.76K 10-Q · filed 2025-11-13 | $24.56K derived: sum of 2 quarters · filed 2025-11-13 | $47.04K 10-Q · filed 2025-11-13 | $536.73K 10-Q · filed 2024-12-06 | |
| 2024-06-30 | $18.80K 10-Q · filed 2025-08-14 | $41.28K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $22.48K 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $82.81K 10-K · filed 2025-03-31 | ||||
| 2017-03-31 | $136.64K 10-Q · filed 2017-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |